Harvard Med School Licenses GNS Healthcare's Big Data Analytics Platform | GenomeWeb

NEW YORK (GenomeWeb News) – Big data analysis firm GNS Healthcare announced today that Harvard Medical School is licensing its REFS analytics platform for the characterization and elucidation of signaling and transcriptional events in biological systems.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genome sequencing study of Yakutian horses, tardigrade genome, and more.

A guest post at Retraction Watch discusses what funders can do to improve research reproducibility.

Researchers report in Nature this week that farming led to genomic adaptations in humans.

The FDA argues that it needs to evaluate the safety and efficacy of laboratory-developed tests, a proposal that divides Republicans.